Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Ohm Laboratories, Inc.
483
•Ohm Laboratories, Inc.•August 12, 2009

Ohm Laboratories, Inc. – FDA 483, Aug 12, 2009

Record Details

This FDA Form 483 documents numerous deficiencies observed during an inspection. The facility failed to include distributed drug product quantities in annual reports and did not submit an NDA-Field Alert Report within three working days for a distributed batch failing specifications.

Significant quality system and manufacturing issues were identified: - Inadequate testing and record-keeping for drug product expiration dates. - Absence of written production and process control procedures to assure drug product identity, strength, quality, and purity. - Failure to document written production and process control procedures at the time of performance. - Incomplete investigations into batch failures, not extending to other potentially affected batches or products. - Unwritten and unfollowed responsibilities and procedures for the quality control unit. - Insufficient qualified personnel for processing drug products. - Lack of employee training in specific operations and GMP procedures. - Deficient complaint records lacking investigation findings. - Unspecified storage conditions in the written stability program for retained samples. - Undescribed sampling and testing plans for drug products in written procedures. - Unverified suitability of testing methods under actual use conditions. - Deficiently written or followed instrument calibration procedures. - Laboratory records lacking second-person review for accuracy and completeness. - Failure to maintain backup files for computer data and lack of backup procedures to ensure data integrity. - Inadequate controls over computer systems to restrict changes to authorized personnel. - Incomplete records for testing and standardization of laboratory

Company
Ohm Laboratories, Inc.
Inspection date
August 12, 2009
Product type
Drugs
Office
New York District Office
People
  • L Capron (other)
  • Stephen A. Campbell, Esq.
View Company Profile

ID · 014fcd7f-7694-42fd-a281-e28974dc7516

Violation Codes10
21 CFR 211.100(a)21 CFR 211.19221 CFR 211.68(b)21 CFR 211.2221 CFR 211.100(b)21 CFR 211.68(a)21 CFR 211.16521 CFR 211.110(a)21 CFR 211.25(a)21 CFR 211.198

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ohm Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.